Literature DB >> 6723258

Statewide mental health outcome evaluation: a perspective of two southern states.

H L McPheeters.   

Abstract

The states of Georgia and Tennessee implemented statewide outcome assessment programs in a number of their community mental health programs. Georgia used a Role Functioning Scale which was developed for this purpose. The system was implemented statewide and tied to quality assurance. Tennessee used the Quality of Life Questionnaire and the Program Impact Monitoring System developed in Oregon and implemented the system on a volunteer basis in six community programs. Both systems had some successes and encountered some difficulties which are described. Fiscal constraints have curtailed both systems, but suggestions are made for statewide outcome assessment projects based on these experiences.

Mesh:

Year:  1984        PMID: 6723258     DOI: 10.1007/BF00754103

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  1 in total

1.  Goal attainment scaling: A general method for evaluating comprehensive community mental health programs.

Authors:  T J Kiresuk; R E Sherman
Journal:  Community Ment Health J       Date:  1968-12
  1 in total
  42 in total

1.  The prospective relationships among intrinsic motivation, neurocognition, and psychosocial functioning in schizophrenia.

Authors:  Eri Nakagami; Maanse Hoe; John S Brekke
Journal:  Schizophr Bull       Date:  2010-05-12       Impact factor: 9.306

2.  How family factors impact psychosocial functioning for African American consumers with schizophrenia.

Authors:  Joseph Guada; Maanse Hoe; Reta Floyd; Jack Barbour; John S Brekke
Journal:  Community Ment Health J       Date:  2010-12-19

3.  Behavioral approach and avoidance in schizophrenia: an evaluation of motivational profiles.

Authors:  L Felice Reddy; Michael F Green; Shemra Rizzo; Catherine A Sugar; Jack J Blanchard; Raquel E Gur; Ann M Kring; William P Horan
Journal:  Schizophr Res       Date:  2014-08-19       Impact factor: 4.939

4.  A dual change model of life satisfaction and functioning for individuals with schizophrenia.

Authors:  Melissa Edmondson; Rohini Pahwa; Karen Kyeunghae Lee; Maanse Hoe; John S Brekke
Journal:  Schizophr Res       Date:  2012-05-14       Impact factor: 4.939

5.  Adapting social neuroscience measures for schizophrenia clinical trials, part 3: fathoming external validity.

Authors:  Charles M Olbert; David L Penn; Robert S Kern; Junghee Lee; William P Horan; Steven P Reise; Kevin N Ochsner; Stephen R Marder; Michael F Green
Journal:  Schizophr Bull       Date:  2013-09-26       Impact factor: 9.306

6.  The relationships among perceived criticism, family contact, and consumer clinical and psychosocial functioning for African-American consumers with schizophrenia.

Authors:  Joseph Guada; John S Brekke; Reta Floyd; Jack Barbour
Journal:  Community Ment Health J       Date:  2008-10-08

7.  Social Cognitive Skills Training for Psychosis With Community-Based Training Exercises: A Randomized Controlled Trial.

Authors:  William P Horan; Michelle Dolinsky; Junghee Lee; Robert S Kern; Gerhard Hellemann; Catherine A Sugar; Shirley M Glynn; Michael F Green
Journal:  Schizophr Bull       Date:  2018-10-17       Impact factor: 9.306

8.  Further support for the role of dysfunctional attitudes in models of real-world functioning in schizophrenia.

Authors:  William P Horan; Yuri Rassovsky; Robert S Kern; Junghee Lee; Jonathan K Wynn; Michael F Green
Journal:  J Psychiatr Res       Date:  2009-12-14       Impact factor: 4.791

9.  Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome.

Authors:  Gregory P Strauss; William P Horan; Brian Kirkpatrick; Bernard A Fischer; William R Keller; Pinar Miski; Robert W Buchanan; Michael F Green; William T Carpenter
Journal:  J Psychiatr Res       Date:  2013-02-27       Impact factor: 4.791

10.  Characteristics of violent versus nonviolent patients with schizophrenia.

Authors:  R B Flannery; W E Penk; E A Irvin; C Gallagher
Journal:  Psychiatr Q       Date:  1998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.